ACLY and autoimmune polyendocrinopathy: For this purpose, we compared the HR for APS in subjects positive for aCL and/or aβ2GPI but not aDI [aCL/aβ2GPI+(aDI-)] versus subjects with aDI [aCL/aβ2GPI+(aDI+)] (Table 6).